Breaking the Stigma of Athletes Mishandling Money

The fans remember the highlights but the franchises remember the technology, data, and inventions that powered their season. Host Tyler Kern sits down with the innovators, leaders and founders that are taking sports into the future.

 

Professional athletes and entertainers receive large paydays during their careers. However, many lack the knowledge or have the right people around them to not go broke. Wale Ogunleye, who played 11 years in the NFL, wants to change all that by leading UBS’ Athletes and Entertainers Strategic Client Segment. He joined host Tyler Kern on Salary Capped to share his experiences and current mission.

The number one thing new drafts need to realize, Ogunleye said, is that “this is business time.” Players have to know they are the business of football now, and that’s true of anyone signing a lucrative contract.

“We want to support them with the infrastructure to move into being an entrepreneur and businessperson. In investing, you need to know about the business. You wouldn’t go out on the field without knowing the playbook. It’s the same principle.” – Wale Ogunleye

Ogunleye was in the same situation, and he admits he had zero financial literacy during his playing days. He’d like to see the league take a more proactive rather than hands-off approach.

“Give players more life skills, balancing a checkbook, credit score awareness, and vetting those around them and also explaining a contract. There’s so much jargon and complex information. Help players understand it better,” he said.

Because of his experience and so many cautionary tales, Ogunleye has become a disruptor to the industry. “We want to support them with the infrastructure to move into being an entrepreneur and businessperson. In investing, you need to know about the business. You wouldn’t go out on the field without knowing the playbook. It’s the same principle.”

Ogunleye noted that sports stars and entertainers can build their own brands now and go direct to fans through social media. He believes this is the future of monetizing their brand and aligning with companies. To do that, they’ll need guidance and investors they can trust.

At UBS, Ogunleye’s leadership of this new division is about bringing his experiences and the company’s to adapt to new needs and ensure the money they make lasts.

Follow Along for a New Episode Every Monday!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More